Study of VYD2311 for the Prevention of COVID-19
Public ClinicalTrials.gov record NCT07298434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Triple-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VYD2311 for the Prevention of COVID-19 in Adults and Adolescents
Study identification
- NCT ID
- NCT07298434
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Invivyd, Inc.
- Industry
- Enrollment
- 1,770 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- VYD2311-MD Drug
- VYD2311-SD Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
- Last update posted
- May 14, 2026
2026
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Invivyd Investigative Site | Long Beach | California | 90806 | Recruiting |
| Inviviyd Investigative Site | San Diego | California | 92103 | Recruiting |
| Invivyd Investigative Site | Orlando | Florida | 32819 | Recruiting |
| Invivyd Investigative Site | Hinesville | Georgia | 31313 | Recruiting |
| Invivyd Investigative Site | Melrose Park | Illinois | 60160 | Recruiting |
| Invivyd Investigative Site | Lenexa | Kansas | 66219 | Recruiting |
| Invivyd Investigative Site | Silver Spring | Maryland | 20904 | Recruiting |
| Invivyd Investigative Site | Burlington | Massachusetts | 01803 | Recruiting |
| Invivyd Investigative Site | Southfield | Michigan | 48034 | Recruiting |
| Invivyd Investigative Site | Maplewood | Minnesota | 55109 | Recruiting |
| Invivyd Investigative Site | Independence | Missouri | 64055 | Recruiting |
| Invivyd Investigative Site | Jersey City | New Jersey | 07306 | Recruiting |
| Invivyd Investigative Site | The Bronx | New York | 10455 | Recruiting |
| Invivyd Investigative Site | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Invivyd Investigative Site | Myrtle Beach | South Carolina | 29572 | Recruiting |
| Invivyd Investigative Site | Goodlettsville | Tennessee | 37072 | Recruiting |
| Invivyd Investigative Site | Houston | Texas | 77065 | Recruiting |
| Invivyd Investigative Site | Houston-2 | Texas | 77065 | Recruiting |
| Invivyd Investigative Site | Irving | Texas | 75061 | Recruiting |
| Invivyd Investigative Site | Sugar Land | Texas | 46254 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07298434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07298434 live on ClinicalTrials.gov.